Monopar Therapeutics
MNPR
#7583
Rank
โ‚น45.97 B
Marketcap
โ‚น6,785
Share price
-0.94%
Change (1 day)
0.14%
Change (1 year)

EPS for Monopar Therapeutics (MNPR)

EPS in 2026 (TTM): -โ‚น174.50

According to Monopar Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น179.98. In 2025 the company made an earnings per share (EPS) of -โ‚น174.33 an increase over its 2024 EPS that were of -โ‚น387.29.

EPS history for Monopar Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น174.500.1%
2025-โ‚น174.33-54.99%
2024-โ‚น387.2935.2%
2023-โ‚น286.46-26.75%
2022-โ‚น391.0513.7%
2021-โ‚น343.9425.86%
2020-โ‚น273.2728.89%
2019-โ‚น212.0245.28%
2018-โ‚น145.94-80.5%
2017-โ‚น748.471296.33%
2016-โ‚น53.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น127.21-29.32%๐Ÿ‡บ๐Ÿ‡ธ USA